Prestige Wealth Management Group »

Cytek Biosciences shares owned by Prestige Wealth Management Group

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Prestige Wealth Management Group from 13F filings

Historical chart of Prestige Wealth Management Group investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Prestige Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Prestige Wealth Management Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $832 240 3.47

More positions owned by Prestige Wealth Management Group

Wisdomtree Tr Us Qtly Div Grt (DGRW)
Ishares Tr Conv Bd Etf (ICVT)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Broad Usd High (USHY)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Apple (AAPL)
Wisdomtree Tr Us Quality Grow (QGRW)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr Sbi Materials (XLB)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Colgate-Palmolive Company (CL)
Vanguard Index Fds Value Etf (VTV)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Growth Etf (VUG)
Select Sector Spdr Tr Sbi Healthcare (XLV)

View all positions for Prestige Wealth Management Group

Top funds holding Cytek Biosciences

BlackRock
Vanguard Group
Hillhouse Capital Advisors
Brown Capital Management
State Street Corporation
Millennium Management
Dimensional Fund Advisors
Geode Capital Management
Wellington Management Company
Royce & Associates
Goldman Sachs Group
Morgan Stanley
Charles Schwab Investment Management
AQR Capital Management
Northern Trust

View all funds holding Cytek Biosciences